Table 7.
Meta-regression analysis of variables predicting serum and plasma levels of inteleukin-6 comparing obstructive sleep apnea syndrome with controls.
Year of publication | R | Adjusted R2 | P | Mean age of OSAS patients | R | Adjusted R2 | P | Mean age of controls | R | Adjusted R2 | P |
---|---|---|---|---|---|---|---|---|---|---|---|
Serum | 0.001 | −0.029 | 0.995 | Serum | 0.479 | 0.207 | 0.03 | Serum | 0.385 | 0.123 | 0.022 |
Plasma | 0.124 | −0.034 | 0.582 | Plasma | 0.377 | 0.092 | 0.112 | Plasma | 0.204 | −0.018 | 0.417 |
Mean BMI of OSAS patients | R | Adjusted R2 | P | Mean BMI of controls | R | Adjusted R2 | P | Mean AHI of OSAS patients | R | Adjusted R2 | P |
Serum | 0.119 | −0.017 | 0.504 | Serum | 0.089 | −0.023 | 0.615 | Serum | 0.188 | −0.011 | 0.391 |
Plasma | 0.143 | −0.031 | 0.538 | Plasma | 0.168 | −0.032 | 0.504 | Plasma | 0.169 | −0.036 | 0.517 |
Number of participants | R | Adjusted R2 | P | ||||||||
Serum | 0.062 | −0.025 | 0.717 | ||||||||
Plasma | 0.159 | −0.029 | 0.504 |
R, correlation coefficient. Bold numbers for statistically significant values (P < 0.05).